@article{113c00e485534495b086aba3df1e88bb,
title = "Immune checkpoint inhibition by anti-PDCD1 (anti-PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model",
keywords = "CD274 (PD-L1), PDCD1LG2 (PD-L2), anti-PDCD1 (anti-PD1), primary central nervous system lymphoma (PCNSL), survival",
author = "Yushi Qiu and Zhimin Li and Frederic Pouzoulet and Prakash Vishnu and Copland, {John A.} and Knutson, {Keith L.} and Carole Soussain and Tun, {Han W.}",
note = "Funding Information: This work is supported by internal funding from the Mayo Clinic (to Drs Tun and Knutson).",
year = "2018",
month = nov,
doi = "10.1111/bjh.15009",
language = "English (US)",
volume = "183",
pages = "674--678",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "4",
}